摘要
Abstract
Objective To study the clinical effect of bicyclol combined with polyene phosphatidylcholine in treatment of hyperthyroid hepatic dysfunction, in order to provide a reliable medication guidance in the liver protection. Methods The clinical data of 74 patients with hyperthyroid hepatic dysfunction treated in our hospital from July 2013 to July 2015 were retrospectively analyzed. According to the random number table, 74 patients were divided into control group and observation group, with 37 cases in each group. All patients were treated with methimazole, and the control group was given polyene phosphatidylcholine for liver protection, the observation group was given bicyclol combined with polyene phosphatidylcholine. The clinical efficacy and conditions of liver function were compared between two groups. Results The total effective rate of control group was 64.86%, significantly lower than 89.19% of observation group, with statistical difference (P<0.05). The improvement degree of ALT, AST and TBIL in observation group was significantly better than that of control group, with statistical difference (P<0.05). Conclusions For patients with hyperthyroid hepatic dysfunction, bicyclol combined with polyene phosphatidylcholine can effectively reduce the levels of transaminase and bilirubin, improve the liver function, which is worthy of clinical promotion and application.关键词
双环醇/多烯磷脂酰胆碱/甲亢性肝损伤Key words
Bicyclol/Polyene phosphatidylcholine/Hyperthyroid hepatic dysfunction分类
医药卫生
